US Patent Issued on June 30 for "Pharmaceutical composition for oral administration of a GLP-1 receptor agonist" (Moroccan Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,605, issued on June 30.

"Pharmaceutical composition for oral administration of a GLP-1 receptor agonist" was invented by Farid Bennis (Casablanca, Morocco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a pharmaceutical composition for use as a medicament, in the oral treatment of a disease, in particular a metabolic disease, said pharmaceutical composition comprising a Glucagon-like peptide-1 receptor agonist (GLP-1), and a system that can buffer the pH of the pharmaceutical composition to a value ranging from 4 to 8."

The patent was filed on Feb. 24, 2022, under Application No. 18/279,981.

*For further information, includ...